LA PERICARDITE ACUTA IN CORSO DI EMODIALISI PERIODICA. ASPETTI TERAPEUTICI = LA PERICARDITE AIGUE AU COURS DE L'HEMODIALYSE PERIODIQUE. ASPECTS THERAPEUTIQUESDI MARCO V; GINARDI V; MAZZONE O et al.1980; G. ITAL. CARDIOL.; ITA; DA. 1980; VOL. 10; NO 1; PP. 79-83; ABS. ENG; BIBL. 23 REF.Article

RELATIONSHIP BETWEEN BETA -METHYL-DIGOXIN PHARMACOKINETIC AND DEGREE OF RENAL IMPAIRMENTTROVATO GM; DI MARCO V; GINARDI V et al.1983; CURRENT THERAPEUTIC RESEARCH; ISSN 0011-393X; USA; DA. 1983; VOL. 33; NO 1; PP. 158-164; BIBL. 2 P.Article

Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitisCRAXI, A; DI MARCO, V; VOLPES, R et al.Hepato-gastroenterology. 1988, Vol 35, Num 6, pp 304-305, issn 0172-6390Article

Complex formation between aluminium(III) and two hydroxy-aromatic ligands : 2-hydroxyphenylethanone and 2-hydroxybenzeneacetic acidDI MARCO, V. B; TAPPARO, A; BOMBI, G. G et al.Annali di chimica. 1999, Vol 89, Num 5-6, pp 397-407, issn 0003-4592Article

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver diseasePETTA, S; CAMMA, C; CABIBI, D et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 7, pp 757-766, issn 0269-2813, 10 p.Article

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass indexPETTA, S; DI MARCO, V; CAMMA, C et al.Alimentary pharmacology & therapeutics. 2011, Vol 33, Num 12, pp 1350-1360, issn 0269-2813, 11 p.Article

Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage. IVBRIGUGLIO, F; BRIGUGLIO, E; DI MARCO, V et al.Journal of international medical research. 1986, Vol 14, Num 3, pp 115-123, issn 0300-0605Article

Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitisPETTA, S; CAMMA, C; DI MARCO, V et al.Alimentary pharmacology & therapeutics. 2009, Vol 30, Num 6, pp 603-613, issn 0269-2813, 11 p.Article

Combined treatment of relapse of chronic hepatitis C with high-dose α₂b interferon plus ribavirin for 6 or 12 monthsDI MARCO, V; ALMASIO, P; VACCARO, A et al.Journal of hepatology. 2000, Vol 33, Num 3, pp 456-462, issn 0168-8278Article

Transfusion-associated chronic hepatitis C : alpha-n₁ interferon for 6 vs. 12 monthsCRAXI, A; DI MARCO, V; IACONO, O. L et al.Journal of hepatology. 1996, Vol 24, Num 5, pp 539-546, issn 0168-8278Article

Corynebacterium macginleyi isolation from conjunctival swab in ItalyGIAMMANCO, G. M; DI MARCO, V; PRIOLO, I et al.Diagnostic microbiology and infectious disease. 2002, Vol 44, Num 2, pp 205-207, issn 0732-8893, 3 p.Article

Celiac disease and epilepsy in pediatric patients. CommentaryFOIS, A; VASCOTTO, M; DI BARTOLO, R. M et al.Child's nervous system (Print). 1994, Vol 10, Num 7, pp 450-454, issn 0256-7040Conference Paper

Interferon-α for chronic hepatitis C : an analysis of pretreatment clinical predictors of responsePAGLIARO, L; CRAXI, A; CAMMAA, C et al.Hepatology (Baltimore, Md.). 1994, Vol 19, Num 4, pp 820-828, issn 0270-9139Conference Paper

Smouldering hepatitis B virus replication in patients with chronic liver disease and hepatits delta virus superinfectionCOLOMBO, P; DI BLASI, F; MAGRIN, S et al.Journal of hepatology. 1991, Vol 12, Num 1, pp 64-69, issn 0168-8278, 6 p.Article

Metabolic effects of buflomedil hydrochlorideBRIGUGLIO, F; DI MARCO, V; CIRCOSTA, C et al.Journal of international medical research. 1985, Vol 13, Num 3, pp 131-158, issn 0300-0605Article

Duration of HCV infection as a predictor of nonresponse to interferonCRAXI, A; DI MARCO, V; GAMMA, C et al.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 86S-92S, issn 0163-2116, SUPConference Paper

Progressive cerebral calcifications, epilepsy, and celiac diseaseFOIS, A; BALESTRI, P; VASCOTTO, M et al.Brain & development (Tokyo. 1979). 1993, Vol 15, Num 1, pp 79-82, issn 0387-7604Article

Comparison of Transient Elastography and Acoustic Radiation Force Impulse for Non-Invasive Staging of Liver Fibrosis in Patients With Chronic Hepatitis CRIZZO, L; CALVARUSO, Vincenza; NUNNARI, G et al.The American journal of gastroenterology. 2011, Vol 106, Num 12, pp 2112-2120, issn 0002-9270, 9 p.Article

High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis CDI MARCO, V; VACCARO, A; FERRARO, D et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 7, pp 953-958, issn 0269-2813Article

Alpha interferon treatment of chronic hepatitis C in β-thalassaemiaDI MARCO, V; LO IACONO, O; CRAXI, A et al.Gut. 1993, Vol 34, Num 2, pp S142-S143, issn 0017-5749, SUPConference Paper

Oral mucosa of coeliac disease patients produces antiendomysial and antitransglutaminase antibodies: the diagnostic usefulness of an in vitro culture systemCARROCCIO, A; CAMPISI, G; PIRRONE, G et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 12, pp 1471-1477, issn 0269-2813, 7 p.Article

Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferonALMASIO, P. L; DI MARCO, V; CRAXI, A et al.Digestive diseases and sciences. 1999, Vol 44, Num 5, pp 1013-1019, issn 0163-2116Article

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis CDI MARCO, V; LI IACOMO, O; CAMMA, C et al.Journal of medical virology. 1997, Vol 51, Num 1, pp 17-24, issn 0146-6615Article

Expression of leukocyte adhesion molecules in the liver of patients with chronic hepatitis B virus infectionMALIZIA, G; DINO, O; PAGLIARO, L et al.Gastroenterology (New York, NY. 1943). 1991, Vol 100, Num 3, pp 749-755, issn 0016-5085, 7 p.Article

Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver diseasePETTA, S; AMATO, M. C; CRAXI, A et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 2, pp 238-247, issn 0269-2813, 10 p.Article